Abstract
Are Current Educational and Therapeutic Programs, Directed at Rare Disease Transplant Candidates and Recipients, Sufficient to Support Them on the Path From Diagnosis to Life After Allogenic Transplantation?—Recommendations for Member State Policymakers
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have